Skip to content

Insider · CIK 0001693134

Adam Scott Levy

cfoofficer

Files at MLYS (Mineralys Therapeutics, Inc.). First filing Oct 15, 2024, latest Apr 15, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $276k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

MLYS: Mineralys Therapeutics, Inc.

MLYSOct 9, 2026 · close 23.37

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
28Weak
MLYSsell 310b5-1
Mineralys Therapeutics, Inc.
$130k
10,757 shares
-5%+53% from low-21% from high
21Weak
MLYSsell 210b5-1
Mineralys Therapeutics, Inc.
$146k
10,757 shares
-4%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Apr 11, 2025MLYS
Mineralys Therapeutics, Inc.
SOpen-market sale
Common Stock10b5-1
-10,757$12.06$130k215,340Apr 15, 2025
Oct 11, 2024MLYS
Mineralys Therapeutics, Inc.
SOpen-market sale
Common Stock10b5-1
-10,757$13.57$146k236,854Oct 15, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Adam Scott Levy: insider trades and track record | InsiderTell